Serial #79310276
LIVE

Serial Number

79310276

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79310276 Trademark

Serial Number: 79310276 • Registration: 6541780

Serial #79310276 is a trademark filed by NOVARTIS AG on February 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 24, 2021

Registration Date

November 2, 2021

Published for Opposition

August 17, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2022 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Apr 22, 2022 FICS
FINAL DISPOSITION PROCESSED
Apr 22, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 2, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 2, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Aug 22, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 4, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 4, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2021 NONP
REFUSAL PROCESSED BY IB
Jul 19, 2021 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 12, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 9, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 9, 2021 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 1, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 1, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 17, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2021 DOCK
ASSIGNED TO EXAMINER
May 27, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 18, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 13, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 8, 2021 REPR